Markets showed signs of strain this week. Risky trades like crypto and AI stocks saw sharp declines. This sudden sell-off and quick recovery highlighted how fragile the current market cycle has become. Investors are now more cautious, seeking protection against potential downturns. Even strong earnings from companies like Nvidia could not prevent broader market jitters.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,